XBIOTECH INC (XBIT:NASDAQ)

$1.85 -0.08 (-4.1451%)

watchlist-icon
search-icon
Profile Icon

Most Recent Average Sentiment Analysis Score (0 to 100): 82

negative-sentiment
Negative [0, 35)
neutral-sentiment
Neutral [35, 65]
positive-sentiment
Positive (65, 100]
Visualize Sentiment Trendline

Analysed XBIOTECH INC (XBIT:NASDAQ) News Sources

November 2025's Promising Penny Stocks To Watch

12-11-2025

yahoo.com

3 Promising Penny Stocks With Market Caps Over $30M

19-12-2025

yahoo.com

XBiotech Announces Election of Sushma Shivaswamy and Jan-Paul Simard as Co-Chief Executive Officers

23-10-2026

yahoo.com

XBiotech Launches Phase II Clinical Trial Evaluating Vilamakitug for the Treatment of Active Axial Spondyloarthritis

15-06-2026

yahoo.com

XBiotech Announces Positive Phase II Final Efficacy Results from Investigator-Sponsored TASKIN Trial in Refractory Metastatic Colorectal Cancer

19-10-2026

yahoo.com

XBIOTECH INC (XBIT:NASDAQ) Sentiment Trend

0 25 50 75 100 91 92 69 81 76 12-11-2025 19-12-2025 23-10-2026 15-06-2026 19-10-2026 #1 #2 #3 #4 #5 Negative < 35 Neutral 35–65 Positive > 65 View FAQ

XBIOTECH INC (XBIT:NASDAQ) FAQs

toggle

What is the current price of XBIOTECH INC (XBIT:NASDAQ)?

The current price of XBIOTECH INC (XBIT:NASDAQ) is $1.85.


toggle

XBIOTECH INC (XBIT:NASDAQ) absolute price change since previous trading day?

The absolute price change of XBIOTECH INC (XBIT:NASDAQ) since the previous trading day is $-0.08.


toggle

XBIOTECH INC (XBIT:NASDAQ) percentage price change since previous trading day?

The percentage price change of XBIOTECH INC (XBIT:NASDAQ) since the previous trading day is -4.1451%.


toggle

What is the most recent average sentiment score for XBIOTECH INC (XBIT:NASDAQ)?

The most recent average sentiment score for XBIOTECH INC (XBIT:NASDAQ) is 82 out of 100.


toggle

What is the most recent average sentiment for XBIOTECH INC (XBIT:NASDAQ)?

The most recent sentiment for XBIOTECH INC (XBIT:NASDAQ) is .


SEC-8K** Filing Available For XBIOTECH INC (XBIT:NASDAQ)

** material developments that could impact a company's financial condition or stock price.

Author: MattELab

X Icon

GitHub Icon

MattELab is the founder and lead developer of SentientMerchant. With a Computer Science and Quantitative Finance background from a T10 university, he brings over 6 years of expertise in NLP, programmatic SEO, and full-stack development to build highly scalable AI and FinTech solutions.